racicetam with an atypical mechanism: it acts as an agonist at mGluR2 and mGluR3, the presynaptic Glutamate autoreceptors that detect synaptic glutamate and downregulate further release. Activating these reduces glutamate tone. Simultaneously, it upregulates GABA-B receptor density. The net effect is a systematic recalibration of the E/I balance toward baseline, not acutely, but over days to weeks as receptor populations shift.
Extended periods of elevated excitatory tone ( from my use of things like TAK-653 etc ) tend to downregulate inhibitory receptor populations as a homeostatic response. Fasoracetam appears to reverse, in that mGluR2/3 agonism resensitizes the autoreceptor feedback loop, GABA-B GABA Receptor > GABA$_A$ Receptor upregulation restores inhibitory tone. GABA-B upregulation also addresses the restlessness or low-grade anxiety that can accompany Bromantane washout.
- not for our stack, actively reduces glutamate tone that TAK-653 amplifies
- Oral bioavailability modest; subl admin improves absorption meaningfully.
Could have genotype dependent responder variation, as was trield in ADHD patients with mGluR pathway variants